Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)

AIMS: Atrial fibrillation (AF) and thrombo‐embolism (TE) are associated with reduced survival in hypertrophic cardiomyopathy (HCM), but the absolute risk of TE in patients with and without AF is unclear. The primary aim of this study was to derive and validate a model for estimating the risk of TE i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guttmann, Oliver P., Pavlou, Menelaos, O'Mahony, Constantinos, Monserrat, Lorenzo, Anastasakis, Aristides, Rapezzi, Claudio, Biagini, Elena, Gimeno, Juan Ramon, Limongelli, Giuseppe, Garcia‐Pavia, Pablo, McKenna, William J., Omar, Rumana Z., Elliott, Perry M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737264/
https://www.ncbi.nlm.nih.gov/pubmed/26183688
http://dx.doi.org/10.1002/ejhf.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737264/
https://www.ncbi.nlm.nih.gov/pubmed/26183688
http://dx.doi.org/10.1002/ejhf.316

Ejemplares similares